Last $7.40 USD
Change Today +0.09 / 1.23%
Volume 41.9K
CCM On Other Exchanges
Symbol
Exchange
New York
Berlin
As of 4:15 PM 04/24/14 All times are local (Market data is delayed by at least 15 minutes).

concord medical - spon adr (CCM) Snapshot

Open
$7.29
Previous Close
$7.31
Day High
$7.54
Day Low
$7.16
52 Week High
03/5/14 - $10.08
52 Week Low
06/27/13 - $3.51
Market Cap
139.1M
Average Volume 10 Days
88.1K
EPS TTM
$0.33
Shares Outstanding
18.8M
EX-Date
01/16/14
P/E TM
22.3x
Dividend
--
Dividend Yield
9.73%
Current Stock Chart for CONCORD MEDICAL - SPON ADR (CCM)

concord medical - spon adr (CCM) Related Bloomberg News

View More Bloomberg News

concord medical - spon adr (CCM) Related Businessweek News

View More BusinessWeek News

concord medical - spon adr (CCM) Details

Concord Medical Services Holdings Limited, through its subsidiaries, operates a network of radiotherapy and diagnostic imaging centers. Its services include linear accelerators external beam radiotherapy, gamma knife radiosurgery, head gamma knife systems, body gamma knife systems, proton beam therapy, and diagnostic imaging services. The company also offers other treatments and diagnostic services through the use of medical equipment comprising electroencephalography for the diagnosis of epilepsy; thermotherapy for pain relief after radiotherapy and chemotherapy; ultrasound therapy for the treatment of cancer; stereotactic radiofrequency ablation for the treatment of Parkinson’s disease; and refraction and tonometry for the diagnosis of ophthalmic conditions. In addition, it provides clinical support services, such as developing treatment protocols for doctors; and organizing joint diagnosis between doctors in its network and clinical research. Further, the company offers radiotherapy and diagnostic equipment leasing and management services to hospitals, as well as engages in the sale of medical equipment. The company, through its subsidiaries, Cyber Medical and Shanghai Medstar, holds 52% equity interest in Chang’an Hospital with a capacity of 1,100 beds. It also focuses on establishing the Beijing Proton Medical Center and Guangzhou Taihe Cancer Hospital, two specialty cancer hospitals that would offer radiotherapy services to cancer patients, including proton beam therapy. As of March 31, 2013, the Company operated a network of 137 centers with 77 hospital partners in 54 cities and 24 provinces and administrative regions in China. Concord Medical Services Holdings Limited was founded in 1996 and is headquartered in Beijing, the People’s Republic of China.

Founded in 1996

concord medical - spon adr (CCM) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

concord medical - spon adr (CCM) Key Developments

Concord Medical Services Holdings Limited Presents at Macquarie Greater China Healthcare Corporate Day - Shenzhen, Apr-09-2014

Concord Medical Services Holdings Limited Presents at Macquarie Greater China Healthcare Corporate Day - Shenzhen, Apr-09-2014 . Venue: JW Marriott Shenzhen, Shenzhen, China.

Concord Medical Receives Approval to Build Shanghai Concord Cancer Hospital

Concord Medical Services Holdings Limited announced the company will establish Shanghai Concord Cancer Hospital - a premium cancer hospital - in Shanghai New Hongqiao International Medical Center. Shanghai Concord plans to open 400 beds and adapts the domestic and internationally advanced therapeutic methods, medical process and management system. It plans to install the most advanced cancer diagnosis and treatment equipment and multidiscipline system.

Concord Medical Services Holdings Limited Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2013; Provides Earnings Guidance for the Full Year 2014

Concord Medical Services Holdings Limited reported unaudited consolidated earnings results for the fourth quarter and full year ended December 31, 2013. For the quarter, total net revenues increased by 32.7% in the fourth quarter of 2013 to RMB 282.6 million compared to RMB 213.0 million in the fourth quarter of 2012. Non-GAAP net income was RMB 17.1 million, a 54.2% decrease from the fourth quarter of 2012. Both non-GAAP basic and diluted earnings per American depositary share were RMB 0.37. Net income attributable to ordinary shareholders was RMB 13.1 million compared to RMB 31.8 million for the fourth quarter of 2012. Both basic and diluted earnings per ADS for the fourth quarter of 2013 were RMB 0.29. The decrease was mainly due to higher operating expenses and income tax expenses during the fourth quarter. Operating income was RMB 50.5 million compared to RMB 57.4 million a year ago. Adjusted EBITDA (non-GAAP) was RMB 106.2 million, representing a 2.5% decrease from the fourth quarter of 2012. Income before income taxes was $47,870,000 compared to $55,278,000 a year ago. For the full year, total net revenues were RMB 974.6 million, a 47.1% increase from 2012. Non-GAAP net income was RMB 104.0 million, an 29.2% decrease from 2012. Both non-GAAP basic and diluted earnings per ADS for the full year 2013 were RMB 2.19. Net income attributable to ordinary shareholders was RMB 88.4 million compared to RMB 130.8 million for the full year 2012. Both basic and diluted earnings per ADS for the full year 2013 were RMB 1.96. Operating income in 2013 was RMB 174.7 million, a 15.4% decrease from RMB 206.6 million in 2012 mainly due to higher selling expenses in 2013. Operating income excluding share-based compensation expenses (non-GAAP) in 2013 was RMB 185.0 million, representing a 15.5% decrease from 2012. Adjusted EBITDA (non-GAAP) was RMB 396.7 million, representing a 5.7% increase from RMB 375.4 million in 2012. Capital expenditures were RMB 159.8 million compared to RMB 491.9 million in 2012. Income before income taxes was $169,218,000 compared to $196,666,000 a year ago. For the whole year of 2014, the company expects earnings in the range of $0.45 to $0.50 per ADS, or $20.3 million to $22.5 million in Net income attributable to ordinary shareholders. This forecast reflects company’s current and preliminary view, which is subject to change.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CCM:US $7.40 USD +0.09

CCM Competitors

Market data is delayed at least 15 minutes.

Company Last Change
China Renji Medical Group Ltd/Hong Kong $0.04 HKD -0.007
View Industry Companies
 

Industry Analysis

CCM

Industry Average

Valuation CCM Industry Range
Price/Earnings 22.6x
Price/Sales 2.0x
Price/Book 0.9x
Price/Cash Flow 9.4x
TEV/Sales NM Not Meaningful
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CONCORD MEDICAL - SPON ADR, please visit www.cmsholdings.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.